应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MRK 默沙东
盘前交易 03-26 07:45:42 EDT
87.87
-4.44
-4.81%
盘前
88.07
+0.20
+0.23%
07:06 EDT
最高
92.31
最低
87.08
成交量
2,064万
今开
92.31
昨收
92.31
日振幅
5.67%
总市值
2,220亿
流通市值
2,216亿
总股本
25.26亿
成交额
18.33亿
换手率
0.82%
流通股本
25.22亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
默沙东架构调整!成熟产品进集采后,MNC借力创新运营模式
医药经济报 · 03-11
默沙东架构调整!成熟产品进集采后,MNC借力创新运营模式
凌激赴北京市开展“服务保障进外企”专项走访活动并主持召开北京地区外资企业圆桌会
美港电讯 · 03-08
凌激赴北京市开展“服务保障进外企”专项走访活动并主持召开北京地区外资企业圆桌会
由“仿”到“创” 中国医药迈步康庄大道
中国新闻网 · 03-08
由“仿”到“创” 中国医药迈步康庄大道
媒体点赞机构买入,“走红”抗癌药来自“广州制造”
广州日报 · 03-07
媒体点赞机构买入,“走红”抗癌药来自“广州制造”
国产双抗疗效击败全球药王 临床研究结果数据已在《柳叶刀》发表了
第一财经 · 03-07
国产双抗疗效击败全球药王 临床研究结果数据已在《柳叶刀》发表了
金十数据整理:每日美股市场要闻速递(3月6日 周四)
美港电讯 · 03-06
金十数据整理:每日美股市场要闻速递(3月6日 周四)
首个肿瘤疫苗有望在2027年推出,用于治疗这种癌症
第一财经 · 03-06
首个肿瘤疫苗有望在2027年推出,用于治疗这种癌症
首个肿瘤疫苗有望在2027年推出 用于治疗皮肤癌
金十财经 · 03-06
首个肿瘤疫苗有望在2027年推出 用于治疗皮肤癌
【Moderna预计2027年推出与默沙东共同开发的皮肤癌症疫苗】Moderna公司预计将在2027年推出与默沙东共同开发的皮肤癌症疫苗。Moderna公司总裁Stephen Hoge透露,目前正在进行皮肤癌疫苗的后期试验,预期该疫苗可能是成为相当大的收入机会。
金融界 · 03-06
【Moderna预计2027年推出与默沙东共同开发的皮肤癌症疫苗】Moderna公司预计将在2027年推出与默沙东共同开发的皮肤癌症疫苗。Moderna公司总裁Stephen Hoge透露,目前正在进行皮肤癌疫苗的后期试验,预期该疫苗可能是成为相当大的收入机会。
Moderna(MRNA.US)携手默沙东(MRK.US)冲刺2027 一款重磅皮肤癌疫苗进入倒计时
智通财经 · 03-06
Moderna(MRNA.US)携手默沙东(MRK.US)冲刺2027 一款重磅皮肤癌疫苗进入倒计时
传奥洛兹美医疗(HALO.US)将与默沙东(MRK.US)就注射版Keytruda展开专利战
智通财经 · 03-05
传奥洛兹美医疗(HALO.US)将与默沙东(MRK.US)就注射版Keytruda展开专利战
金十数据整理:每日美股市场要闻速递(3月4日 周二)
美港电讯 · 03-04
金十数据整理:每日美股市场要闻速递(3月4日 周二)
默沙东(MRK.US)来特莫韦微片拟纳入CDE优先审评 属儿童新品种
智通财经 · 03-04
默沙东(MRK.US)来特莫韦微片拟纳入CDE优先审评 属儿童新品种
百济神州距离默沙东,差了4个恒瑞医药
蓝鲸财经 · 02-27
百济神州距离默沙东,差了4个恒瑞医药
默沙东(MRK.US)预计2026年畅销药物Keytruda将被纳入美版“集采”谈判
智通财经 · 02-26
默沙东(MRK.US)预计2026年畅销药物Keytruda将被纳入美版“集采”谈判
一次宇宙级合作
瞪羚社 · 02-25
一次宇宙级合作
创新药周报:默沙东HIF-2ɑ抑制剂BELZUTIFAN欧盟获批
华创证券有限责... · 02-23
创新药周报:默沙东HIF-2ɑ抑制剂BELZUTIFAN欧盟获批
特朗普警告制药公司:关税即将到来 应加快将海外生产转移至美国
美港电讯 · 02-22
特朗普警告制药公司:关税即将到来 应加快将海外生产转移至美国
石药集团抗肿瘤新药拟纳入突破性治疗品种,默沙东癌症1类新药在中国获批临床
医药经济报 · 02-21
石药集团抗肿瘤新药拟纳入突破性治疗品种,默沙东癌症1类新药在中国获批临床
默沙东/第一三共肿瘤新药将入临床,能攻破小细胞肺癌治疗难题吗?
界面 · 02-21
默沙东/第一三共肿瘤新药将入临床,能攻破小细胞肺癌治疗难题吗?
加载更多
公司概况
公司名称:
默沙东
所属市场:
NYSE
上市日期:
--
主营业务:
默克制药公司于1970年在新泽西州注册成立。该公司是一家全球医疗保健公司,通过其处方药提供创新的健康解决方案,包括生物疗法、疫苗和动物保健产品。该公司的营运主要以产品为基础进行管理,包括两个经营分部:制药及动物保健国际。
发行价格:
--
{"stockData":{"symbol":"MRK","market":"US","secType":"STK","nameCN":"默沙东","latestPrice":87.87,"timestamp":1742932800000,"preClose":92.31,"halted":0,"volume":20640186,"hourTrading":{"tag":"盘前","latestPrice":88.07,"preClose":87.87,"latestTime":"07:06 EDT","volume":324,"amount":28591.09812,"timestamp":1742987198367},"delay":0,"floatShares":2522065058,"shares":2526036240,"eps":6.74,"marketStatus":"盘前交易","change":-4.44,"latestTime":"03-26 07:45:42 EDT","open":92.31,"high":92.31,"low":87.08,"amount":1832769258.48576,"amplitude":0.056657,"askPrice":88.26,"askSize":106,"bidPrice":88.07,"bidSize":1,"shortable":3,"etf":0,"ttmEps":6.74,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1742995800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":-745790400000,"exchange":"NYSE","adjPreClose":87.87,"dividendRate":0.035052,"preHourTrading":{"tag":"盘前","latestPrice":88.07,"preClose":87.87,"latestTime":"07:06 EDT","volume":324,"amount":28591.09812,"timestamp":1742987198367},"postHourTrading":{"tag":"盘后","latestPrice":88.07,"preClose":87.87,"latestTime":"19:59 EDT","volume":1530627,"amount":134499411.7309,"timestamp":1742947188362},"volumeRatio":0.8717601225610003,"optionData":{"bulkOrders":[{"symbol":"MRK","call":false,"expireDate":1746158400000,"strike":"91.0","timestamp":1742915863668,"price":3.15,"volume":7500,"amount":2362500,"type":"+"},{"symbol":"MRK","call":true,"expireDate":1750392000000,"strike":"105.0","timestamp":1742931687904,"price":0.54,"volume":3470,"amount":187380,"type":"-"}]},"impliedVol":0.4314,"impliedVolPercentile":1},"requestUrl":"/m/hq/s/MRK","defaultTab":"news","newsList":[{"id":"2518955753","title":"默沙东架构调整!成熟产品进集采后,MNC借力创新运营模式","url":"https://stock-news.laohu8.com/highlight/detail?id=2518955753","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518955753?lang=zh_cn&edition=full","pubTime":"2025-03-11 11:07","pubTimestamp":1741662449,"startTime":"0","endTime":"0","summary":"默沙东中国近日向员工公布了组织架构的最新调整。此次新设的企业家事业部便是默沙东创新业务运营模式的正式落地。据悉,这一事业部由默沙东中国原糖尿病事业部负责人史家维负责,将采用独特的企业家模式进行运营,整合肿瘤、院内专科医疗和糖尿病领域的成熟产品,成为极具凝聚力的整体。在业内看来,此次默沙东中国的组织架构调整,是其面对集采政策和市场变化做出的重要战略决策,但实际运营效果如何,还有待观察。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503111112519640e49c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503111112519640e49c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999002224.SGD","LU1037948541.HKD","IE00BLSP4452.SGD","IE00BLSP4239.USD","LU0985320562.USD","MRK","LU1934455277.USD","BK4007","IE00BJT1NW94.SGD","LU0106261372.USD","LU0965508806.USD","LU1585245621.USD","LU0965509010.AUD","IE00BSNM7G36.USD","LU1057294990.SGD","SGXZ57979304.SGD","LU1162221912.USD","BK4559","LU1116320901.HKD","IE00BFTCPJ56.SGD","SG9999014559.SGD","LU1066051498.USD","LU1093756168.USD","LU1917777945.USD","BK4534","LU1989772923.USD","IE0002141913.USD","LU2361044949.HKD","IE00BN8TJ469.HKD","LU0289739699.SGD","LU1093756325.SGD","IE00B1BXHZ80.USD","LU0070302665.USD","LU0234572021.USD","LU0211331839.USD","BK4533","BK4585","LU1035773651.USD","LU1066051225.USD","BK4516","LU0265550946.USD","SG9999015358.SGD","LU1941712348.USD","IE000M9KFDE8.USD","LU0861579265.USD","LU0203345920.USD","IE00B4R5TH58.HKD","LU1941712264.USD","SG9999001440.SGD","LU0965509101.SGD"],"gpt_icon":0},{"id":"2517844328","title":"凌激赴北京市开展“服务保障进外企”专项走访活动并主持召开北京地区外资企业圆桌会","url":"https://stock-news.laohu8.com/highlight/detail?id=2517844328","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517844328?lang=zh_cn&edition=full","pubTime":"2025-03-08 19:30","pubTimestamp":1741433415,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU2065171311.SGD","LU0192582467.USD","LU1699723380.USD","LU1093756168.USD","IE000W1ABFV2.USD","LU0873338254.USD","LU0084288322.USD","LU1629891620.HKD","LU1852331112.SGD","LU1988902786.USD","LU2106854487.HKD","SONY","LU0326948709.USD","IE00BKPKM429.USD","LU1267930730.SGD","LU2471134879.HKD","LU0820561909.HKD","LU1989764664.SGD","LU1868836914.USD","LU0235996351.USD","AMZN","USAW.SI","SG9999002232.USD","IE0009356076.USD","SBUX","0O59.UK","LU0096364046.USD","LU1868836591.USD","D05.SI","BK4504","SGXZ43160589.SGD","LU2361044949.HKD","LU0861579265.USD","LU2756315318.SGD","LU0689472784.USD","LU0314104364.USD","MRK","IE00B19Z8X17.USD","LU1983299246.USD","LU1974910355.USD","LU0950375773.USD","LU2360032135.SGD","LU0417517546.SGD","SG9999015358.SGD","LU1127390331.HKD","LU1929549753.HKD","LU0345768153.USD","SGXZ51526630.SGD","LU0823397285.USD","LU2089984988.USD"],"gpt_icon":0},{"id":"2517443140","title":"由“仿”到“创” 中国医药迈步康庄大道","url":"https://stock-news.laohu8.com/highlight/detail?id=2517443140","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517443140?lang=zh_cn&edition=full","pubTime":"2025-03-08 19:14","pubTimestamp":1741432448,"startTime":"0","endTime":"0","summary":"【由“仿”到“创” 中国医药迈步康庄大道】“最近,一家名不见经传的中国企业生产的新药击败了全世界最畅销的抗癌药。”全国政协委员、中国医学科学院肿瘤医院主任医师赵宏在全国政协十四届三次会议首场“委员通道”上分享了一则令人振奋的消息。记者了解到,创造这一成绩的中国药企是康方生物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503083340394015.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503083340394015.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1035773651.USD","LU1057294990.SGD","LU1934455194.USD","IE00B4R5TH58.HKD","LU0265550359.USD","LU1989771016.USD","SG9999014567.USD","LU0320765646.SGD","IE00BJJMRZ35.SGD","LU1989772840.SGD","MRK","LU0234572021.USD","SG9999001176.SGD","LU0965509283.SGD","SG9999014575.USD","LU0208291251.USD","SGXZ57979304.SGD","06978","LU1720050803.USD","LU1571399168.USD","LU1066051498.USD","LU2106854487.HKD","LU2361044949.HKD","SG9999001176.USD","LU0985320562.USD","LU1934455277.USD","LU0965509010.AUD","SG9999013999.USD","LU1974910355.USD","SG9999014559.SGD","09926","BK4007","IE00B543WZ88.USD","LU1794554557.SGD","IE00B2B36J28.USD","IE00B5MMRT66.SGD","LU1066053197.SGD","LU1066051811.HKD","IE000M9KFDE8.USD","LU1116320737.USD","LU0070302665.USD","BK1161","LU2361045086.USD","LU0238689110.USD","LU0203345920.USD","IE00BSNM7G36.USD","LU1162221912.USD","LU1066051225.USD","BK4516","LU0122379950.USD"],"gpt_icon":0},{"id":"2517809494","title":"媒体点赞机构买入,“走红”抗癌药来自“广州制造”","url":"https://stock-news.laohu8.com/highlight/detail?id=2517809494","media":"广州日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517809494?lang=zh_cn&edition=full","pubTime":"2025-03-07 20:55","pubTimestamp":1741352152,"startTime":"0","endTime":"0","summary":"近期一款“名不见经传”的抗癌药走红。广州日报新花城记者采访获悉:这款药物来自“广州制造”——广州康方药业生产的依沃西是全球首创双特异性抗体新药(商品名“依达方?”),不但可以消灭肿瘤,还能抑制肿瘤血管生长,抑制肿瘤扩散。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503073339990630.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1066051225.USD","SG9999001176.USD","LU2023250843.SGD","LU1066053197.SGD","LU0965509283.SGD","LU1941712348.USD","LU0238689110.USD","LU1162221912.USD","LU0106261372.USD","LU0861579265.USD","LU1037948897.HKD","SG9999001440.SGD","IE00BSNM7G36.USD","IE00BLSP4239.USD","LU0289739699.SGD","IE00B5MMRT66.SGD","LU0320765489.SGD","MRK","LU2488822045.USD","LU2468319806.SGD","LU0417516571.SGD","IE00B4R5TH58.HKD","LU2106854487.HKD","IE00BBT3K403.USD","LU0006306889.USD","SG9999015341.SGD","LU1983299246.USD","LU1941712264.USD","LU2361045086.USD","LU1057294990.SGD","LU2361044865.SGD","LU0203347892.USD","LU0965509010.AUD","LU1929549753.HKD","LU1430594728.SGD","LU2112291526.USD","LU0320765646.SGD","LU1934455277.USD","SG9999002224.SGD","SG9999001176.SGD","SG9999013999.USD","LU1989772923.USD","LU1585245621.USD","09926","IE00B1BXHZ80.USD","LU1794554557.SGD","LU0208291251.USD","SG9999014559.SGD","LU0203345920.USD","BK1161"],"gpt_icon":0},{"id":"2517910639","title":"国产双抗疗效击败全球药王 临床研究结果数据已在《柳叶刀》发表了","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910639","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517910639?lang=zh_cn&edition=full","pubTime":"2025-03-07 17:00","pubTimestamp":1741338046,"startTime":"0","endTime":"0","summary":"【国产双抗疗效击败全球药王 临床研究结果数据已在《柳叶刀》发表了】去年9月8日,国产企业康方生物(09926.HK)双抗药物依沃西,从疗效上战胜了全球药王帕博利珠单抗(即“K药”)的消息传开后,引发资本市场沸腾。时至今日,康方生物港股股价涨幅在50%左右。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503073339808148.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503073339808148.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0211331839.USD","IE00BLSP4239.USD","LU0985320562.USD","PFS","LU1023059063.AUD","LU1720050803.USD","LU0203345920.USD","LU1941712264.USD","IE00BBT3K403.USD","LU1093756325.SGD","LU0320765489.SGD","LU0238689110.USD","SG9999014575.USD","BK4007","LU2324357040.USD","BK4585","09926","IE00B1BXHZ80.USD","LU1989771016.USD","LU0106261372.USD","LU0265550946.USD","LU2089984988.USD","LU1066051498.USD","BK4550","SG9999002224.SGD","SG9999002232.USD","MRK","LU0348784397.USD","IE00BJJMRZ35.SGD","LU1066053197.SGD","LU0208291251.USD","SG9999001176.SGD","BK4534","SGXZ57979304.SGD","IE00BJT1NW94.SGD","LU1989772840.SGD","LU0265550359.USD","LU0070302665.USD","LU0320765646.SGD","BK1161","LU2361044865.SGD","LU1116320737.USD","LU2361044949.HKD","LU1061106388.HKD","LU2488822045.USD","LU1699723380.USD","LU0965509010.AUD","LU1057294990.SGD","IE000M9KFDE8.USD","LU1794554557.SGD"],"gpt_icon":0},{"id":"2517150640","title":"金十数据整理:每日美股市场要闻速递(3月6日 周四)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517150640","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517150640?lang=zh_cn&edition=full","pubTime":"2025-03-06 21:50","pubTimestamp":1741269018,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["AMZN","09939","NVDL","JD","NVD3.UK","UMC","IE00BZ1G4Q59.USD","LOGI","03145","159938","NVDY","AAPL","TWmain","NVDA","HPQ","2NVD.UK","TSLA","INTC","RTX","TSLL","TSM","3NVD.UK","TSYW.SI","SNVD.UK","XMAG","159646","GOOG","NVDS.UK","IE0009356076.USD","09618","IBM","MACW.SI","MSFT","META","NVDD","BABA","MRNA","NVDX","NVD2.UK","09988","NVD","NVDS","NVIW.SI","EWT","MRK","MU","89618","DDL","QCOM","NVDU"],"gpt_icon":1},{"id":"2517418031","title":"首个肿瘤疫苗有望在2027年推出,用于治疗这种癌症","url":"https://stock-news.laohu8.com/highlight/detail?id=2517418031","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517418031?lang=zh_cn&edition=full","pubTime":"2025-03-06 16:03","pubTimestamp":1741248208,"startTime":"0","endTime":"0","summary":"当地时间3月5日,美国疫苗厂商Moderna在投资者会议上表示,该公司有望于2027年推出首个肿瘤疫苗。当天收盘,Moderna股价大涨近16%。Moderna正在与默沙东共同开发一款个性化的肿瘤疫苗,并已对严重的皮肤癌(黑色素瘤)患者进行后期临床试验。Moderna公司总裁StephenHoge在周三的投资者会议上表示,首款肿瘤疫苗可能有机会为公司带来“相当大的收入”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503063338506797.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503063338506797.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SGXZ57979304.SGD","BK4533","LU1989772923.USD","BK4588","LU0234572021.USD","BK4516","IE0009355771.USD","LU1066051811.HKD","BK4559","IE00B1BXHZ80.USD","LU1162221912.USD","LU2023250504.SGD","SG9999001176.USD","LU0058720904.USD","LU0266013472.USD","LU0289739699.SGD","LU1983299246.USD","LU0965509010.AUD","LU0985320562.USD","SG9999001440.SGD","SG9999002224.SGD","LU1069347547.HKD","IE0002141913.USD","LU0203345920.USD","LU2023250843.SGD","BK4550","LU1585245621.USD","LU0265550946.USD","LU1989772840.SGD","LU2361045086.USD","IE00BLSP4239.USD","LU0070302665.USD","LU1037948541.HKD","LU1291159041.SGD","LU1571399168.USD","MRK","LU1934455277.USD","IE00BLSP4452.SGD","LU0265550359.USD","LU2361044949.HKD","LU2112291526.USD","SG9999014567.USD","IE000M9KFDE8.USD","LU0106261372.USD","LU0965509283.SGD","LU1917777945.USD","LU0965509101.SGD","BK4585","LU1699723380.USD","LU0211331839.USD"],"gpt_icon":0},{"id":"2517187515","title":"首个肿瘤疫苗有望在2027年推出 用于治疗皮肤癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2517187515","media":"金十财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517187515?lang=zh_cn&edition=full","pubTime":"2025-03-06 16:01","pubTimestamp":1741248092,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://flash-api.jin10.com/get_flash_list?channel=2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_jinshicaijing","symbols":["SGXZ57979304.SGD","LU0238689110.USD","159646","BK4007","IE00BLSP4452.SGD","LU0265550946.USD","LU1929549753.HKD","LU2106854487.HKD","IE0002141913.USD","LU1061106388.HKD","LU1989772840.SGD","SG9999001176.USD","LU1917777945.USD","LU1093756168.USD","IE00BLSP4239.USD","LU0208291251.USD","LU0106261372.USD","LU1934455194.USD","LU1934455277.USD","BK4559","BK4534","LU1989771016.USD","LU1023059063.AUD","LU0203345920.USD","LU0965509101.SGD","IE00BFTCPJ56.SGD","SG9999014575.USD","LU1037948897.HKD","LU0266013472.USD","LU2361044865.SGD","IE00B4R5TH58.HKD","SG9999014542.SGD","SG9999015341.SGD","LU2324357040.USD","LU1066051811.HKD","LU0203347892.USD","LU1941712264.USD","LU1116320737.USD","SG9999014567.USD","SG9999015358.SGD","MRK","LU1066053197.SGD","LU1291159041.SGD","LU2361044949.HKD","BK4585","03347","BK4516","SG9999002232.USD","IE00B2B36J28.USD","SG9999001440.SGD"],"gpt_icon":0},{"id":"2517290589","title":"【Moderna预计2027年推出与默沙东共同开发的皮肤癌症疫苗】Moderna公司预计将在2027年推出与默沙东共同开发的皮肤癌症疫苗。Moderna公司总裁Stephen Hoge透露,目前正在进行皮肤癌疫苗的后期试验,预期该疫苗可能是成为相当大的收入机会。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517290589","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517290589?lang=zh_cn&edition=full","pubTime":"2025-03-06 10:54","pubTimestamp":1741229648,"startTime":"0","endTime":"0","summary":"Moderna公司预计将在2027年推出与默沙东共同开发的皮肤癌症疫苗。Moderna公司总裁Stephen Hoge透露,目前正在进行皮肤癌疫苗的后期试验,预期该疫苗可能是成为相当大的收入机会。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06105448555932.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1699723380.USD","LU1093756325.SGD","LU1983299246.USD","LU2324357040.USD","LU2461242641.AUD","SG9999002224.SGD","LU2106854487.HKD","LU1571399168.USD","SG9999001440.SGD","SG9999014575.USD","LU1023059063.AUD","LU1037948541.HKD","IE00BSNM7G36.USD","LU0106261372.USD","LU1974910355.USD","IE00B1BXHZ80.USD","LU1989772923.USD","LU1116320737.USD","LU0211331839.USD","BK4516","IE00B2B36J28.USD","LU1069347547.HKD","LU1430594728.SGD","MRK","SG9999001176.USD","IE00BN8TJ469.HKD","LU0122379950.USD","LU0238689110.USD","LU1585245621.USD","LU0965508806.USD","BK4585","SG9999002232.USD","IE00BLSP4239.USD","LU1093756168.USD","IE0002141913.USD","LU1989772840.SGD","LU1989771016.USD","LU2361045086.USD","LU1057294990.SGD","BK4533","IE00BBT3K403.USD","SG9999014542.SGD","SG9999014567.USD","LU2361044865.SGD","LU1061106388.HKD","LU1116320901.HKD","SG9999015358.SGD","159646","LU1941712264.USD","SG9999014559.SGD"],"gpt_icon":0},{"id":"2517469974","title":"Moderna(MRNA.US)携手默沙东(MRK.US)冲刺2027 一款重磅皮肤癌疫苗进入倒计时","url":"https://stock-news.laohu8.com/highlight/detail?id=2517469974","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517469974?lang=zh_cn&edition=full","pubTime":"2025-03-06 09:11","pubTimestamp":1741223492,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,mRNA疫苗领域领军者Moderna 计划在2027年获得其与美国医药巨头默沙东合作开发的个性化皮肤癌疫苗的正式市场批准,这是一种针对皮肤癌的个性化精准疫苗,Moderna一名高管在美东时间周三的一场投资者活动上宣布。在周三举行的TD Cowen美国医疗健康大会上,Moderna总裁斯蒂芬·霍格指出,旨在测试该公司皮肤癌疫苗V940针对黑色素瘤疗效的后期阶段试验已完成全部受试者入组。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258336.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1069347547.HKD","LU1934455863.HKD","LU0965508806.USD","LU1093756168.USD","LU0203345920.USD","LU1941712348.USD","LU0238689110.USD","LU2461242641.AUD","LU0965509101.SGD","IE00B1BXHZ80.USD","LU1035773651.USD","LU0203347892.USD","LU1934455277.USD","LU0265550946.USD","SG9999013999.USD","LU0965509010.AUD","LU0106261372.USD","159646","LU2361044865.SGD","LU0320765646.SGD","IE00BN8TJ469.HKD","LU1116320901.HKD","LU1983299246.USD","BK4568","BK4501","LU2112291526.USD","LU1037948541.HKD","LU1430594728.SGD","IE00BBT3K403.USD","LU0211331839.USD","LU2023250504.SGD","LU2361044949.HKD","SG9999001176.USD","SG9999014542.SGD","LU2324357040.USD","LU1929549753.HKD","SG9999014559.SGD","LU1571399168.USD","LU1974910355.USD","MRNA","SG9999001176.SGD","BK4548","IE0009355771.USD","SG9999014575.USD","LU0965509283.SGD","MRK","LU1066051811.HKD","LU0208291251.USD","LU2106854487.HKD","BK4588"],"gpt_icon":1},{"id":"2517912810","title":"传奥洛兹美医疗(HALO.US)将与默沙东(MRK.US)就注射版Keytruda展开专利战","url":"https://stock-news.laohu8.com/highlight/detail?id=2517912810","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517912810?lang=zh_cn&edition=full","pubTime":"2025-03-05 21:41","pubTimestamp":1741182111,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,据报道,奥洛兹美医疗 与默沙东之间正在酝酿一场新的专利纠纷,争议的焦点是抗癌重磅药物Keytruda的注射版。知情人士透露,奥洛兹美医疗认为默沙东侵犯了其专利,应该签订许可协议才能销售注射用Keytruda。Keytruda几乎贡献了默沙东一半的总营收。默沙东去年表示,其注射版Keytruda在关键的3期试验中达到了主要目标。据报道,奥洛兹美医疗将在周三的投资者活动上讨论注射版Keytruda专利问题。截至发稿,默沙东盘前跌0.54%,奥洛兹美医疗涨0.81%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0965509101.SGD","LU1983299246.USD","LU2023250843.SGD","LU1934455194.USD","LU1934455277.USD","IE00BBT3K403.USD","IE0002141913.USD","LU1035773651.USD","LU1291159041.SGD","LU1066051225.USD","LU0238689110.USD","IE00B1BXHZ80.USD","LU0965509283.SGD","SG9999013999.USD","LU1917777945.USD","LU1989772840.SGD","LU2023250504.SGD","SG9999014575.USD","SG9999002224.SGD","IE00BSNM7G36.USD","LU0965509010.AUD","LU1699723380.USD","LU1093756168.USD","LU1571399168.USD","LU1989772923.USD","SG9999002232.USD","LU1066053197.SGD","LU1066051498.USD","LU2089984988.USD","MRK","LU1023059063.AUD","LU0265550359.USD","BK4534","LU2106854487.HKD","SG9999015358.SGD","BK4007","SG9999015341.SGD","LU1066051811.HKD","IE00BJT1NW94.SGD","LU0122379950.USD","LU1093756325.SGD","LU1162221912.USD","LU0053671581.USD","LU1585245621.USD","BK4139","LU1116320737.USD","LU1974910355.USD","LU0203347892.USD","HALO","LU1037948897.HKD"],"gpt_icon":0},{"id":"2516671650","title":"金十数据整理:每日美股市场要闻速递(3月4日 周二)","url":"https://stock-news.laohu8.com/highlight/detail?id=2516671650","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516671650?lang=zh_cn&edition=full","pubTime":"2025-03-04 21:50","pubTimestamp":1741096236,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["SG9999018865.SGD","LU1116320901.HKD","LU0889566641.SGD","LU2458330243.SGD","SEA","IE00B19Z3B42.SGD","IE0004091025.USD","SGXZ31699556.SGD","LU2125154778.USD","MRK","BK4552","BK4503","LU0985320562.USD","LU1839511570.USD","TSLL","TSM","BK4585","TSYW.SI","LU0061475181.USD","LU0823414478.USD","159813","SE","EWT","LU1868836757.USD","UBER","GB00BDT5M118.USD","SG9999002620.SGD","CDE","IE00BWXC8680.SGD","LU1868837300.USD","LU0820561818.USD","TWmain","03145","LU1861220033.SGD","SG9999014542.SGD","BK4591","LU1116320737.USD","LU2756315664.SGD","BK4533","LU0823421333.USD","BK4505","LU0265550946.USD","LU2663582299.SGD","TSLA","LU0737861269.HKD","LU0820561909.HKD","SG9999014484.SGD","SG9999014559.SGD","BK4588","LU0516422366.SGD"],"gpt_icon":0},{"id":"2516756386","title":"默沙东(MRK.US)来特莫韦微片拟纳入CDE优先审评 属儿童新品种","url":"https://stock-news.laohu8.com/highlight/detail?id=2516756386","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516756386?lang=zh_cn&edition=full","pubTime":"2025-03-04 20:47","pubTimestamp":1741092466,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,今日,中国国家药监局药品审评中心官网刚刚公示,默沙东申报的来特莫韦微片拟纳入优先审评,用于接受异基因造血干细胞移植的巨细胞病毒血清学阳性的成人和6个月及以上且体重≥6kg的儿童受者[R+]预防巨细胞病毒感染和巨细胞病毒病。根据CDE公示,来特莫韦微片属于儿童新品种。研究表明,这些患者当中,巨细胞病毒的血清阳性率可高达90%以上。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1257711.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0211331839.USD","CDE","LU2361044949.HKD","LU2023250843.SGD","LU1093756168.USD","LU1162221912.USD","BK4516","LU2361044865.SGD","SG9999001440.SGD","LU1571399168.USD","LU0265550946.USD","LU1066051498.USD","LU2468319806.SGD","BK4588","LU1934455277.USD","LU0266013472.USD","IE00BBT3K403.USD","LU0058720904.USD","LU1291159041.SGD","LU0122379950.USD","MRK","LU1057294990.SGD","BK4559","SG9999002224.SGD","LU1066051225.USD","LU0234572021.USD","SG9999014567.USD","IE00BLSP4239.USD","LU0208291251.USD","BK4534","LU0320765489.SGD","LU0265550359.USD","LU1037948897.HKD","LU1035773651.USD","LU2361045086.USD","SG9999014575.USD","LU0203347892.USD","LU0965509283.SGD","BK4585","BK4007","LU1066053197.SGD","LU0861579265.USD","BK4550","LU2106854487.HKD","LU1974910355.USD","IE00B1BXHZ80.USD","IE000M9KFDE8.USD","LU1093756325.SGD","IE00B4R5TH58.HKD","LU1116320901.HKD"],"gpt_icon":0},{"id":"2514887138","title":"百济神州距离默沙东,差了4个恒瑞医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2514887138","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514887138?lang=zh_cn&edition=full","pubTime":"2025-02-27 18:11","pubTimestamp":1740651093,"startTime":"0","endTime":"0","summary":"直到近期,百济神州以3100余亿元的A股市值暂时超越恒瑞医药,这场“医药一哥”的易主才引起短暂讨论。百济神州60%收入来自海外,而恒瑞医药仍然依赖国内市场。此次市值跃迁的核心驱动力,源自百济神州打造的核心产品“泽布替尼”。泽布替尼在2024年前三季度的销售额为18.2亿美元。默沙东的“Keytruda”,以294.8亿美元销售额蝉联“药王”,覆盖40个肿瘤适应症。百济神州现有管线中,约90%聚焦于肿瘤治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/251845","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["IE00BJT1NW94.SGD","LU2023250504.SGD","LU1989772923.USD","LU0265550946.USD","IE00BBT3K403.USD","SG9999001176.SGD","SG9999015341.SGD","LU0234572021.USD","LU0203347892.USD","LU0265550359.USD","LU0588546209.SGD","BK4559","SG9999002224.SGD","LU2328871848.SGD","LU0208291251.USD","LU1983299246.USD","ONC","LU0203345920.USD","LU1057294990.SGD","SG9999014559.SGD","MRK","SG9999015358.SGD","IE0002141913.USD","LU1023059063.AUD","IE00BSNM7G36.USD","LU1917777945.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU1116320737.USD","SG9999014575.USD","LU1989771016.USD","LU0965509283.SGD","LU1585245621.USD","LU1934455277.USD","BK4588","LU1037948541.HKD","IE00BJJMRZ35.SGD","LU1061106388.HKD","LU0985320562.USD","LU1093756168.USD","06160","LU2361045086.USD","LU1941712348.USD","LU1571399168.USD","BK4533","LU0320765489.SGD","LU1093756325.SGD","LU1066051498.USD","LU1037948897.HKD","LU0266013472.USD"],"gpt_icon":1},{"id":"2514003956","title":"默沙东(MRK.US)预计2026年畅销药物Keytruda将被纳入美版“集采”谈判","url":"https://stock-news.laohu8.com/highlight/detail?id=2514003956","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514003956?lang=zh_cn&edition=full","pubTime":"2025-02-26 14:13","pubTimestamp":1740550416,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,默沙东表示,预计明年其最畅销的药物Keytruda将被美国政府选中进行价格谈判。默沙东表示:“公司预计,到2026年,HHS将把Keytruda纳入后续选择的产品中,进行IRA定价,价格将于2028年1月1日生效,因此公司预计,Keytruda在美国的销售将在那之后下降。”默沙东报告2024年总销售额为642亿美元,其中Keytruda贡献295亿美元。据报道,Keytruda的关键专利也将于2028年到期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254505.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SG9999014542.SGD","LU0965509010.AUD","LU0203345920.USD","LU2112291526.USD","LU2324357040.USD","LU1983299246.USD","LU1941712264.USD","LU1093756325.SGD","LU2023250504.SGD","LU0006306889.USD","MRK","IE00BSNM7G36.USD","LU0861579265.USD","LU0234572021.USD","LU0985320562.USD","LU1057294990.SGD","BK4516","LU0122379950.USD","SG9999002232.USD","LU1917777945.USD","LU2468319806.SGD","IE00BLSP4239.USD","LU1989772923.USD","IE00BFTCPJ56.SGD","LU0203347892.USD","LU1066051498.USD","LU0965508806.USD","SG9999002224.SGD","SG9999013999.USD","SG9999015358.SGD","LU1699723380.USD","LU1061106388.HKD","LU0265550946.USD","LU1941712348.USD","LU1023059063.AUD","IE00BLSP4452.SGD","IE0002141913.USD","LU2461242641.AUD","IE00BJT1NW94.SGD","LU2089984988.USD","IE000M9KFDE8.USD","SG9999001440.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","IE00B1BXHZ80.USD","LU1066051811.HKD","LU0106261372.USD","LU1934455863.HKD","IE00BN8TJ469.HKD","LU1989772840.SGD"],"gpt_icon":1},{"id":"2514072060","title":"一次宇宙级合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2514072060","media":"瞪羚社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514072060?lang=zh_cn&edition=full","pubTime":"2025-02-25 20:05","pubTimestamp":1740485100,"startTime":"0","endTime":"0","summary":"01辉瑞目前的困境众所周知,宇宙药厂辉瑞在新冠期间靠疫苗和特效药发了横财,并且在2024年,它都是制药业务板块营收最高的MNC。排名第一的是派柏西利,治疗乳腺癌的CDK4/6抑制剂,小分子爆款单品的代表,排名第二的是恩杂鲁胺,治疗前列腺癌的抗雄激素受体小分子。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226124834abdd4ad3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226124834abdd4ad3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PFE","BK4588","LU1162221912.USD","LU1023059063.AUD","LU0006306889.USD","SG9999001176.USD","IE00BSNM7G36.USD","BK4568","LU0170899867.USD","BK4550","MRK","LU1983299246.USD","BK4599","LU2023250843.SGD","LU0208291251.USD","LU1037948897.HKD","SG9999002224.SGD","LU1934455277.USD","SG9999014575.USD","LU0456855351.SGD","LU0058720904.USD","LU0320765489.SGD","LU1116320901.HKD","LU1093756325.SGD","LU0070302665.USD","LU2361045086.USD","LU1934455863.HKD","LU2468319806.SGD","IE00BJJMRZ35.SGD","BK4139","SGXZ57979304.SGD","BK4592","LU2361044949.HKD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU1989772840.SGD","LU0266013472.USD","LU1894683264.USD","LU1066053197.SGD","LU0225284248.USD","LU1291159041.SGD","SMMT","SG9999001176.SGD","LU1585245621.USD","LU2089984988.USD","LU0238689110.USD","SG9999013999.USD","LU0203347892.USD","LU2106854487.HKD","LU0211331839.USD"],"gpt_icon":0},{"id":"2513767345","title":"创新药周报:默沙东HIF-2ɑ抑制剂BELZUTIFAN欧盟获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2513767345","media":"华创证券有限责...","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513767345?lang=zh_cn&edition=full","pubTime":"2025-02-24 00:00","pubTimestamp":1740326400,"startTime":"0","endTime":"0","summary":"目前发现受到HIF调节的RNA超过7000种,涉及肿瘤发生的各个阶段,包括上调VEGF的产生,以诱发适应性的血管生成。目前RCC的治疗方案主要是以VEGF疗法以及免疫制剂作为骨架治疗。2021年8月,首个HIF-2ɑ抑制剂——默沙东的WELIREG?HIF-2ɑ抑制剂2月18日,默沙东宣布欧盟委员会也已有条件批准WELIREG?WELIREG目前已在30多个国家获批用于治疗经治的晚期RCC成年患者,并在40多个国家获批用于治疗某些符合条件的VHL病相关肿瘤成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224092309962dcb57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224092309962dcb57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0208291251.USD","IE00B2B36J28.USD","LU2023250843.SGD","LU1069347547.HKD","LU1699723380.USD","BK4559","LU1093756168.USD","LU1585245621.USD","LU2023250504.SGD","SG9999013999.USD","LU1066053197.SGD","LU1116320737.USD","LU0965508806.USD","BK4550","IE00BLSP4452.SGD","LU1066051225.USD","LU1430594728.SGD","LU1934455194.USD","IE0002141913.USD","IE00BBT3K403.USD","LU0320765489.SGD","LU2089984988.USD","LU1291159041.SGD","BK4534","SG9999002232.USD","IE0009355771.USD","LU0006306889.USD","LU0265550359.USD","LU0203347892.USD","LU1066051498.USD","LU2361044865.SGD","LU2361044949.HKD","LU1934455277.USD","LU0861579265.USD","LU2461242641.AUD","BK4533","MRK","LU1093756325.SGD","SG9999001176.USD","IE00B4R5TH58.HKD","LU1974910355.USD","SG9999015341.SGD","IE00BJJMRZ35.SGD","SG9999015358.SGD","BK4585","LU0238689110.USD","LU1941712348.USD","SG9999014567.USD","IE00BJT1NW94.SGD","LU1057294990.SGD"],"gpt_icon":1},{"id":"2513851241","title":"特朗普警告制药公司:关税即将到来 应加快将海外生产转移至美国","url":"https://stock-news.laohu8.com/highlight/detail?id=2513851241","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513851241?lang=zh_cn&edition=full","pubTime":"2025-02-22 08:14","pubTimestamp":1740183298,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU1894683264.USD","LU0861579265.USD","IE00B19Z3581.USD","01477","LU0456855351.SGD","IE0002270589.USD","LU1548497426.USD","LU1868837300.USD","LU0320765489.SGD","LU0689472784.USD","LU0079474960.USD","LU0321505439.SGD","LU2237443895.HKD","SG9999014575.USD","SG9999017495.SGD","LU1934455277.USD","SG9999014542.SGD","LU0114720955.EUR","IE00BLSP4239.USD","BK4585","MRK","LU0256863811.USD","PFE","IE00B1BXHZ80.USD","LU0203202063.USD","LU0256863902.USD","LU0985320562.USD","LU0820561909.HKD","SG9999014559.SGD","BK4007","BK1574","BK4581","LU1061106388.HKD","LU1066053197.SGD","LU0096364046.USD","LU1551013425.SGD","LU0238689110.USD","LU1934455194.USD","LU1037948541.HKD","LU1066051225.USD","LU2023250504.SGD","SG9999014914.USD","LU2237438978.USD","IE00BFTCPJ56.SGD","LU2324357040.USD","LU0094547139.USD","SG9999015945.SGD","LLY","SG9999018857.SGD","IE00BBT3K403.USD"],"gpt_icon":0},{"id":"2513693782","title":"石药集团抗肿瘤新药拟纳入突破性治疗品种,默沙东癌症1类新药在中国获批临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2513693782","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513693782?lang=zh_cn&edition=full","pubTime":"2025-02-21 19:18","pubTimestamp":1740136713,"startTime":"0","endTime":"0","summary":"此前临床已有口服制剂的西罗莫司获批,用于预防接受肾移植患者的器官排斥。默沙东癌症1类新药在中国获批临床日前,中国国家药监局药品审评中心最新公示,默沙东申报的1类新药注射用MK-6070获得临床试验默示许可,拟开发治疗小细胞肺癌。根据公开渠道查询,本次是该产品首次在中国获批IND。两家公司将在全球范围内共同分担研发和商业化费用,而默沙东将收到1.7亿美元的预付款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221193538abd78288&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221193538abd78288&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1951186391.HKD","LU1226288170.HKD","SG9999004220.SGD","LU1152091168.USD","IE0008369823.USD","IE00BZ08YS42.EUR","BK1515","LU0501845795.SGD","IE00B031HY20.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU1226288253.USD","LU1960683339.HKD","MRK","LU1807302812.USD","LU0072913022.USD","IE00BZ08YT58.USD","LU0880133367.SGD","IE0008368742.USD","IE00BZ08YR35.GBP","LU1008478684.HKD","LU1226287529.USD","LU1226287875.USD","LU0326950275.SGD","01093","BK1521","BK1191","LU1152091754.HKD","LU1993786604.SGD","LU0067412154.USD","LU0140636845.USD","LU1226287792.SGD"],"gpt_icon":1},{"id":"2513225192","title":"默沙东/第一三共肿瘤新药将入临床,能攻破小细胞肺癌治疗难题吗?","url":"https://stock-news.laohu8.com/highlight/detail?id=2513225192","media":"界面","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513225192?lang=zh_cn&edition=full","pubTime":"2025-02-21 16:53","pubTimestamp":1740128032,"startTime":"0","endTime":"0","summary":"界面新闻记者 |黄华界面新闻编辑 |许悦2月21日,据国家药监局药品审评中心公示,默沙东申报的1类新药注射用MK-6070已获得临床试验默示许可,拟开发治疗小细胞肺癌。这意味着,这款在研新药将在中国进入临床研究阶段。2024年8月,默沙东升级了和第一三共的合作。2024年12月初,MK-6070在国内递交了的临床申请。在人类攻克肿瘤的路途上,小细胞肺癌仍属于较为缺乏新机制药物的领域。在今年1月,ZL-1310也获得了治疗小细胞肺癌的孤儿药认定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221170242abd75354&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221170242abd75354&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1934455863.HKD","LU2089984988.USD","IE00BJT1NW94.SGD","IE00BLSP4239.USD","LU1061106388.HKD","LU1057294990.SGD","LU0208291251.USD","IE0009355771.USD","LU1066051811.HKD","LU2361044949.HKD","SG9999002224.SGD","SGXZ57979304.SGD","LU0965509283.SGD","LU1941712348.USD","MRK","LU1917777945.USD","LU1934455194.USD","IE00B2B36J28.USD","LU1989772840.SGD","LU2461242641.AUD","LU0070302665.USD","LU1037948897.HKD","LU1066053197.SGD","BK4588","LU1037948541.HKD","IE00B1BXHZ80.USD","LU1974910355.USD","LU0965508806.USD","LU1989771016.USD","IE00BFTCPJ56.SGD","LU0006306889.USD","LU1585245621.USD","LU2023250504.SGD","SG9999001440.SGD","LU0203347892.USD","LU2106854487.HKD","BK4516","LU2468319806.SGD","LU0106261372.USD","LU0320765646.SGD","LU0861579265.USD","LU1291159041.SGD","LU1116320901.HKD","SG9999001176.USD","LU0985320562.USD","SG9999014542.SGD","LU1093756168.USD","LU0203345920.USD","LU0058720904.USD","BK4550"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.merck.com","stockEarnings":[{"period":"1week","weight":-0.0723},{"period":"1month","weight":-0.0182},{"period":"3month","weight":-0.1164},{"period":"6month","weight":-0.223},{"period":"1year","weight":-0.2988},{"period":"ytd","weight":-0.1167}],"compareEarnings":[{"period":"1week","weight":0.0257},{"period":"1month","weight":-0.0408},{"period":"3month","weight":-0.043},{"period":"6month","weight":0.0055},{"period":"1year","weight":0.1071},{"period":"ytd","weight":-0.0181}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"默克制药公司于1970年在新泽西州注册成立。该公司是一家全球医疗保健公司,通过其处方药提供创新的健康解决方案,包括生物疗法、疫苗和动物保健产品。该公司的营运主要以产品为基础进行管理,包括两个经营分部:制药及动物保健国际。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.009524},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.001865},{"month":3,"riseRate":0.622222,"avgChangeRate":-0.003324},{"month":4,"riseRate":0.622222,"avgChangeRate":0.018595},{"month":5,"riseRate":0.644444,"avgChangeRate":0.018719},{"month":6,"riseRate":0.511111,"avgChangeRate":0.01265},{"month":7,"riseRate":0.488889,"avgChangeRate":0.003443},{"month":8,"riseRate":0.488889,"avgChangeRate":0.001677},{"month":9,"riseRate":0.533333,"avgChangeRate":-0.006327},{"month":10,"riseRate":0.533333,"avgChangeRate":0.018591},{"month":11,"riseRate":0.711111,"avgChangeRate":0.028573},{"month":12,"riseRate":0.6,"avgChangeRate":0.013993}],"exchange":"NYSE","name":"默沙东","nameEN":"Merck"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"默沙东,MRK,默沙东股票,默沙东股票老虎,默沙东股票老虎国际,默沙东行情,默沙东股票行情,默沙东股价,默沙东股市,默沙东股票价格,默沙东股票交易,默沙东股票购买,默沙东股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}